Chemcel Bio-tech IPO GMP History
Chemcel Bio-tech IPO has been listed on October 13, 2008 at a listing price of ₹16, against the issue price of ₹16 — a gain of ₹0 (+0%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Chemcel Bio-tech IPO raised ₹24.64 Cr. through its IPO at a price band of TBA per share, with a lot size of 350 shares. The IPO was open for subscription from 09 Sep 2008 to 12 Sep 2008.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 8:16 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Chemcel Bio-tech IPO dates
Key dates from opening to listing. Today is 13 November.
- Open 09 Sep 2008
- Close 12 Sep 2008
- Allotment TBA
- Refund/credit TBA
- Listing 13 Oct 2008
Chemcel Bio-tech IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹16 |
|---|---|
| Listing gain / loss | +₹0 per share |
| Listing date | 13 Oct, 2008 |
| Actual listing price | ₹16 (+0%) |
Is Chemcel Bio-tech IPO GMP reliable?
Grey market premium for Chemcel Bio-tech IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Chemcel Bio-tech IPO full review for a fundamentals-based assessment before making any grey market trades.
Chemcel Bio-tech IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Chemcel Bio-tech IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Chemcel Bio-tech IPO
Chemcel Bio-tech Limited was incorporated as Chemcel Products Limited on 29 September 1995 in Andhra Pradesh and has its registered office at Auto Nagar, Vijayawada. Its promoters are Kanuparthi Balakrishna Rao, Kanuparthi Trinadha Vijaya Kumar and Kanuparthi Chandra Shekar Prasad.
It was set up mainly to make agrochemicals, and Andhra Pradesh, its home market, is India's largest state market for agrochemicals.
It also had a bio fertiliser division and was setting up a bio diesel unit.
The IPO was Rs 24.64 crore at a fixed price of Rs 16. The money was for the bio diesel unit, working capital for its agrochemical and bio fertiliser division and repaying loans.
Frequently asked
What is the GMP of Chemcel Bio-tech IPO?
The current Grey Market Premium (GMP) of Chemcel Bio-tech IPO is not yet started or active in the market.
What is the Kostak Price of Chemcel Bio-tech IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Chemcel Bio-tech IPO is not available.
What is the Subject to Sauda Price of Chemcel Bio-tech IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Chemcel Bio-tech IPO?
Chemcel Bio-tech IPO listed on October 13, 2008 at ₹16, against the issue price of ₹16 — a gain of +0%.
How did the GMP of Chemcel Bio-tech IPO trend before listing?
The GMP of Chemcel Bio-tech IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Chemcel Bio-tech IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
